INHIBRX
Live / Registered — Registered and renewed (as of 25 Mar 2022)
What this means for you
Registered since 10 Jan 2012. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 10 Jan 2022).
Record
- Serial number
- 85321519
- Registration number
- 4083111
- Mark type
- Stylized text
- Filed
- 16 May 2011
- Published for opposition
- 25 Oct 2011
- Registered
- 10 Jan 2012
- Next maintenance due
- 10 Jan 2022
- Attorney of record
- Andrew D. Skale
Goods and services
- Class 042 — Scientific and technological services: Research and development of therapeutic antibodies and pharmaceuticals, and research and development of technology in the field of therapeutic antibodies and pharmaceuticals
Owner
- INHIBRX BIOSCIENCES, INC., LA JOLLA, CA, US
- INHIBRX, INC., LA JOLLA, DE, US
- TENIUM THERAPEUTICS, INC., LA JOLLA, CA, US
- INHIBRX, LP, LA JOLLA, CA, US
- Inhibrx, LLC, La Jolla, CA, US
- Inhibrx, LLC, La Jolla, CA, US
- Inhibrx, LLC, La Jolla, CA, US
Prosecution history
- 13 Jun 2024 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 25 Mar 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 25 Mar 2022 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 25 Mar 2022 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 25 Mar 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 18 Nov 2021 — TEAS SECTION 8 & 9 RECEIVED
- 10 Jan 2021 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 12 Sept 2018 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 22 Aug 2018 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 17 Jul 2017 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 16 Jul 2017 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 16 Jul 2017 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 23 May 2017 — TEAS SECTION 8 & 15 RECEIVED
- 10 Jan 2017 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 23 Sept 2015 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP